As International Business Machine (IBM) Stock Declined, Holder Jolley Asset Management Has Increased Its Holding; As Macrogenics (MGNX) Stock Value Rose, First Light Asset Management Trimmed by $1.48 Million Its Stake

May 24, 2018 - By Maria Brooks

First Light Asset Management Llc decreased its stake in Macrogenics Inc (MGNX) by 51.5% based on its latest 2017Q4 regulatory filing with the SEC. First Light Asset Management Llc sold 78,112 shares as the company’s stock rose 22.09% while stock markets declined. The institutional investor held 73,558 shares of the health care company at the end of 2017Q4, valued at $1.40M, down from 151,670 at the end of the previous reported quarter. First Light Asset Management Llc who had been investing in Macrogenics Inc for a number of months, seems to be less bullish one the $922.54M market cap company. The stock increased 0.18% or $0.04 during the last trading session, reaching $21.86. About 48,365 shares traded. MacroGenics, Inc. (NASDAQ:MGNX) has risen 31.18% since May 24, 2017 and is uptrending. It has outperformed by 19.63% the S&P500.

Jolley Asset Management Llc increased its stake in International Business Machine (IBM) by 684.93% based on its latest 2017Q4 regulatory filing with the SEC. Jolley Asset Management Llc bought 3,000 shares as the company’s stock declined 0.39% with the market. The institutional investor held 3,438 shares of the computer manufacturing company at the end of 2017Q4, valued at $527,000, up from 438 at the end of the previous reported quarter. Jolley Asset Management Llc who had been investing in International Business Machine for a number of months, seems to be bullish on the $132.16 billion market cap company. The stock decreased 0.48% or $0.7 during the last trading session, reaching $143.97. About 1.57M shares traded. International Business Machines Corporation (NYSE:IBM) has declined 12.58% since May 24, 2017 and is downtrending. It has underperformed by 24.13% the S&P500.

Among 11 analysts covering MacroGenics (NASDAQ:MGNX), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. MacroGenics had 25 analyst reports since August 6, 2015 according to SRatingsIntel. Citigroup downgraded MacroGenics, Inc. (NASDAQ:MGNX) rating on Thursday, August 4. Citigroup has “Neutral” rating and $32 target. The firm has “Buy” rating given on Monday, August 10 by Zacks. BTIG Research maintained it with “Buy” rating and $28.0 target in Wednesday, October 25 report. As per Thursday, September 17, the company rating was initiated by Citigroup. The stock of MacroGenics, Inc. (NASDAQ:MGNX) earned “Equal-Weight” rating by Morgan Stanley on Thursday, February 25. As per Friday, April 6, the company rating was initiated by Leerink Swann. On Tuesday, December 20 the stock rating was initiated by SunTrust with “Buy”. The company was maintained on Wednesday, October 25 by Leerink Swann. The firm earned “Buy” rating on Monday, October 19 by Citigroup. The stock of MacroGenics, Inc. (NASDAQ:MGNX) has “Buy” rating given on Thursday, August 6 by Stifel Nicolaus.

Analysts await MacroGenics, Inc. (NASDAQ:MGNX) to report earnings on August, 1. They expect $-1.18 earnings per share, down 3.51% or $0.04 from last year’s $-1.14 per share. After $-1.34 actual earnings per share reported by MacroGenics, Inc. for the previous quarter, Wall Street now forecasts -11.94% EPS growth.

First Light Asset Management Llc, which manages about $154.73 million and $364.66 million US Long portfolio, upped its stake in Halozyme Therapeutics Inc (NASDAQ:HALO) by 21,800 shares to 467,646 shares, valued at $9.48 million in 2017Q4, according to the filing. It also increased its holding in Harvard Bioscience Inc (NASDAQ:HBIO) by 522,369 shares in the quarter, for a total of 4.64 million shares, and has risen its stake in Iridex Corp (NASDAQ:IRIX).

Investors sentiment decreased to 1.11 in Q4 2017. Its down 0.47, from 1.58 in 2017Q3. It worsened, as 14 investors sold MGNX shares while 31 reduced holdings. 15 funds opened positions while 35 raised stakes. 28.26 million shares or 1.97% more from 27.72 million shares in 2017Q3 were reported. Stifel Fincl Corporation stated it has 0% of its portfolio in MacroGenics, Inc. (NASDAQ:MGNX). Dafna Cap Management Lc has invested 1.58% in MacroGenics, Inc. (NASDAQ:MGNX). Rhumbline Advisers holds 34,200 shares. Private Capital Advisors Incorporated holds 17,500 shares or 0.12% of its portfolio. Point72 Asia (Hong Kong) Limited stated it has 69 shares. Proshare Limited Liability stated it has 0% of its portfolio in MacroGenics, Inc. (NASDAQ:MGNX). Teacher Retirement Systems Of Texas stated it has 0% of its portfolio in MacroGenics, Inc. (NASDAQ:MGNX). Bank & Trust Of Ny Mellon Corp stated it has 153,121 shares or 0% of all its holdings. Renaissance Technologies Ltd owns 300,523 shares or 0.01% of their US portfolio. State Street has 0% invested in MacroGenics, Inc. (NASDAQ:MGNX) for 1.05 million shares. Spark Inv Limited Liability Company holds 0.16% or 154,600 shares. Bb Biotech Ag has invested 1.39% in MacroGenics, Inc. (NASDAQ:MGNX). First Light Asset Mgmt Ltd Liability Corporation invested in 0.38% or 73,558 shares. Mufg Americas holds 64 shares or 0% of its portfolio. Jacobs Levy Equity holds 0.05% or 148,036 shares.

Since January 16, 2018, it had 0 buys, and 7 insider sales for $1.10 million activity. Wigginton Jon Marc sold $100,000 worth of stock. Risser Eric Blasius sold 1,000 shares worth $25,005. Karrels James had sold 5,000 shares worth $155,000 on Monday, March 5.

More important recent MacroGenics, Inc. (NASDAQ:MGNX) news were published by: Globenewswire.com which released: “MacroGenics to Present at Deutsche Bank Health Care Conference” on May 07, 2018, also Bizjournals.com published article titled: “Md. biotech to be acquired by New Jersey pharmaceutical goliath”, Globenewswire.com published: “MacroGenics Announces Date of First Quarter 2018 Financial Results Conference Call” on April 30, 2018. More interesting news about MacroGenics, Inc. (NASDAQ:MGNX) was released by: Seekingalpha.com and their article: “MacroGenics’ (MGNX) CEO Scott Koenig on Q1 2018 Results – Earnings Call Transcript” with publication date: May 08, 2018.

Since January 31, 2018, it had 1 insider purchase, and 2 sales for $2.69 million activity. 5,000 shares were sold by Gherson Diane J, worth $780,000. Another trade for 610 shares valued at $99,659 was made by WADDELL FREDERICK H on Wednesday, January 31.

Investors sentiment increased to 1.03 in 2017 Q4. Its up 0.29, from 0.74 in 2017Q3. It is positive, as 54 investors sold IBM shares while 604 reduced holdings. 156 funds opened positions while 519 raised stakes. 504.07 million shares or 2.90% less from 519.10 million shares in 2017Q3 were reported. Penbrook Management Llc stated it has 0.23% of its portfolio in International Business Machines Corporation (NYSE:IBM). The Massachusetts-based Boston Management has invested 0.35% in International Business Machines Corporation (NYSE:IBM). Autus Asset Lc reported 0.11% stake. Wade G W And Inc has 10,558 shares. Deutsche Bankshares Ag invested in 0.56% or 5.74 million shares. Baker Avenue Asset Mngmt Ltd Partnership accumulated 1.36% or 91,673 shares. Ar Asset, a California-based fund reported 52,192 shares. Mariner Wealth Advsrs Ltd Limited Liability Company owns 26,370 shares. 3,818 are held by Argent Co. Visionary Asset Inc stated it has 17,100 shares or 0.73% of all its holdings. Truenorth holds 0.19% of its portfolio in International Business Machines Corporation (NYSE:IBM) for 2,724 shares. Moreover, Tokio Marine Asset Mgmt Ltd has 0.11% invested in International Business Machines Corporation (NYSE:IBM) for 4,865 shares. Savings Bank Of Hawaii accumulated 5,535 shares. Focused Wealth Management reported 13,452 shares stake. 11,854 are owned by Riverhead Ltd Llc.

Among 33 analysts covering International Business Machines (NYSE:IBM), 13 have Buy rating, 4 Sell and 16 Hold. Therefore 39% are positive. International Business Machines had 129 analyst reports since July 21, 2015 according to SRatingsIntel. JMP Securities maintained the stock with “Market Outperform” rating in Tuesday, July 19 report. As per Tuesday, August 22, the company rating was maintained by KeyBanc Capital Markets. Bank of America upgraded the stock to “Buy” rating in Thursday, November 10 report. The stock of International Business Machines Corporation (NYSE:IBM) earned “Hold” rating by Wedbush on Thursday, January 18. The firm earned “Market Perform” rating on Tuesday, July 19 by BMO Capital Markets. Citigroup maintained it with “Neutral” rating and $160 target in Tuesday, July 19 report. The company was maintained on Wednesday, April 19 by RBC Capital Markets. The firm has “Hold” rating given on Tuesday, April 19 by Cantor Fitzgerald. The firm earned “Sell” rating on Friday, January 19 by Societe Generale. The firm earned “Hold” rating on Sunday, November 26 by BMO Capital Markets.

Jolley Asset Management Llc, which manages about $208.23 million and $157.12M US Long portfolio, decreased its stake in Nucor Corp (NYSE:NUE) by 5,000 shares to 1,221 shares, valued at $78,000 in 2017Q4, according to the filing. It also reduced its holding in Schlumberger Ltd (NYSE:SLB) by 15,327 shares in the quarter, leaving it with 31,427 shares, and cut its stake in General Electric Company (NYSE:GE).

More notable recent International Business Machines Corporation (NYSE:IBM) news were published by: Prnewswire.com which released: “IBM Leads ‘Call for Code’ to Use Cloud, Data, AI, Blockchain for Natural Disaster Relief” on May 24, 2018, also Bizjournals.com with their article: “IBM commits $30M for tech to aid natural disaster relief” published on May 24, 2018, Prnewswire.com published: “EU’s $24 Billion AI Investment Signals Healthcare Big Data Boom” on May 24, 2018. More interesting news about International Business Machines Corporation (NYSE:IBM) were released by: Seekingalpha.com and their article: “Berkshire Hathaway drops IBM” published on May 04, 2018 as well as 247Wallst.com‘s news article titled: “IBM, Abandoned by Buffett and Wall Street, Sinks Lower” with publication date: May 07, 2018.

International Business Machines Corporation (NYSE:IBM) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>